| Category | Zepbound | Mounjaro | |-----------------------------------|------------------------------------------------|------------------------------------------------| | FDA Approval Indication | Obesity and overweight management (with comorbidities) | Type 2 diabetes management | | Year of FDA Approval | 2023 | 2022 | | Active Ingredient | Tirzepatide | Tirzepatide | | Dose Range | 2.5 mg to 15 mg once weekly | 2.5 mg to 15 mg once weekly | | Primary Clinical Purpose | Weight loss | Blood sugar control | | GLP-1/GIP Activity | Dual agonist (GLP-1 + GIP) | Dual agonist (GLP-1 + GIP) | | Average Weight Loss (in trials) | Up to 22.5% of body weight in SURMOUNT-1 study | Up to 15% of body weight in SURPASS studies | | Insulin Sensitivity Impact | Improves insulin sensitivity in patients with obesity | Improves insulin sensitivity in type 2 diabetes patients | | Delivery Method | Single-use auto-injector pen, subcutaneous injection | Single-use auto-injector pen, subcutaneous injection | | Dosing Frequency | Once weekly | Once weekly | | Manufacturer | Eli Lilly | Eli Lilly | | Common Side Effects | Nausea, vomiting, diarrhea, constipation, decreased appetite | Nausea, vomiting, diarrhea, constipation, decreased appetite | | Insurance Coverage | Variable

Traditional Medical Weight Loss Clinics Some Jacksonville weight loss clinics offer GLP-1 but embed it within expensive comprehensive programs requiring upfront fees of $1,000-$3,000+, mandatory purchases of meal replacements or supplements, and long-term contracts with limited flexibility
Esta pluma est diseada para el escalamiento de la dosis y terapia de mantenimiento en la dosis de 0,5 mg
29,37 The biological basis of these differences remains poorly understood, and current evidence is largely derived from adult populations
In this article, we will talk through the benefits of taking collagen at different times of day, as well as which method works best for you
Cecilia Low Wang, predicts that the study results related to the cardiovascular effects of semaglutide the generic name for the drug used in Wegovy and Ozempic could have far-reaching impacts